Table 1.

Baseline Characteristics.

	Discontinuation n = 76	Continuation n = 95	P Value
Mean age (SD)	71 (±11.7)	71 (±12.1)	.92
Mean symptom onset history in days (SD)	6 (±4.4)	6 (±4.7)	.94
Mean antiplatelet days (SD)	1.4 (±2.9)	8.1 (±5.1)	<.05
Male sex (%)	40 (53)	57 (60)	.42
Race (%)			<.05
Black	42 (55)	35 (37)	<.05
White	20 (26)	39 (41)	.06
Other	14 (18)	21 (22)	.69
Preadmission antiplatelet regimen (%)			.68
Aspirin	59 (78)	69 (73)	.57
Clopidogrel	6 (8)	13 (14)	.34
Aspirin + clopidogrel	9 (12)	10 (11)	.98
Other	2 (3)	3 (3)	1
Death while DNR and/or DNI (%)	23 (30)	10 (11)	<.05
Admission from long-term care facility (%)	23 (30)	22 (23)	.38
Oxygen supplementation prior to admission (%)	2 (3)	4 (4)	.69
Any hydroxychloroquine during admission (%)	59 (78)	85 (89)	.06
Any Tocilizumab during admission (%)	8 (11)	6 (6)	.48
Any anticoagulation ≥50% of admission (%)	59 (78)	81 (85)	.28
Any therapeutic anticoagulation	13 (17)	13 (14)	.68
Any prophylactic anticoagulation	54 (71)	74 (78)	.40
Any corticosteroid during admission (%)	23 (30)	22 (23)	.38
Initial white blood cell value (IQR)	6.9 (5.4–9.8) n = 75	6.2 (4.8–8.1) n = 95	.08
Initial hemoglobin value (IQR)	12.6 (10.3–14) n = 75	12.6 (11.4–14.1) n = 95	.36
Initial hematocrit value (IQR)	39.4 (32–43.1) n = 75	38.4 (35–43.1) n = 95	.55
Initial platelet value (IQR)	181 (148–251) n = 75	198 (148–275) n = 95	.28
PT in first 48 hours of admission (IQR)	14.3 (13.4–15.4) n = 24	12.8 (12.4–13.9) n = 11	<.05
PTT in first 48 hours of admission (IQR)	29.7 (29.1–32.4) n = 20	30.1 (27.3–31.6) n = 8	.78
INR in first 48 hours of admission (IQR)	1.3 (1.2–1.4) n = 25	1.1 (1.1–1.2) n = 13	<.05
D-dimer in first 48 hours of admission (IQR)	731 (17–714) n = 24	439 (72–538) n = 28	.13
Fibrinogen in first 48 hours of admission (IQR)	700 (643–700) n = 21	662 (552–700) n = 6	.25

SD, standard deviation; DNR, do not resuscitate; DNI, do not intubate; IQR, interquartile range.